Does anyone have any clue as to why NH is still continuing to fall with no bottom in sight? For all the other hospital sector players like Apollo, Fortis, Max, etc., I can see the intensity of the fall somewhat tapering down and indications of a bottom forming, while NH continues to fall steeply every single day.
Given that their P/E multiple is lower than other competitors and that their strategy is primarily centered around patient volumes and not pricing, I would think that any regulatory setback should affect them to a lesser degree. Am I getting something wrong here? Is NH overvalued with respect to competition?
Subscribe To Our Free Newsletter |